期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Landscape of PD-1/PD-L1 Regulation and Targeted Immunotherapy 被引量:8
1
作者 Jieming Ni Anping Ni 《Chinese Medical Sciences Journal》 CAS CSCD 2018年第3期174-182,共9页
Programmed cell death protein 1(PD-1)/programmed death ligand 1(PD-L1)is a significant immune checkpoint,and the dysfunction of this axis contributes to tumor metastasis and immune escape.PI3K/Akt/mTOR and MAPK signal... Programmed cell death protein 1(PD-1)/programmed death ligand 1(PD-L1)is a significant immune checkpoint,and the dysfunction of this axis contributes to tumor metastasis and immune escape.PI3K/Akt/mTOR and MAPK signal network induces PD-1/PD-L1 expression and facilitates tumor progression.Transcriptional factors such as hypoxia induced factors,PTEN,p53,CDK5,BRD4,STAT modulate PD-1/PDL1 expression.PD-1/PD-L1 level is also regulated via epigenetic and post-translational manner.The underlying mechanisms mentioned above may provide potential targets for tumor treatment.At present,the combination therapy of PD-1/PD-L1 monoclonal antibodies plus small molecular inhibitors has achieved good outcomes in tumor treatment. 展开更多
关键词 programmed cell DEATH protein 1/programmed DEATH LIGAND 1 IMMUNOTHERAPY REGULATION clinical TRIAL inhibitors
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部